value was Ͻ1.6 g/L for cTnI. The reported reference value for cTnT was Ͻ0.1 g/L [4] . To verify the URL for cTnT, cTnI and cTnT were measured in 50 patients admitted to our hospital for suspected myocardial infarction. The relationship between cTnI (x) and cTnT (y) was y ϭ 0.147x Ϫ 0.144 (r ϭ 0.900). Thus, a theoretical URL of 0.09 g/L for cTnT was obtained, which is same as that recommended by the manufacturer.
cTnI and cTnT were measured in 15 patients (median age, 59 years; range, 24 -90 years; sex, 12 men and 3 women) with early posttraumatic rhabdomyolysis in the first 24 h after admission to the hospital. Four patients presented no detectable cTnI at admission, and the cTnT ranged from 0.01 to 0.038 g/L, therefore being under the URL for cTnT. In these patients, CK was up to 480-fold above the URL. For the other patients (with increased CK from 31-to 1450-fold above the URL) with detectable cTnI at admission, a second analysis was performed 24 h later. Fig. 1 shows a close relationship (r ϭ 0.837) between cTnI and cTnT for the 14 patients (24 samples) with rhabdomyolysis: 8 patients had both cTnI and cTnT below their respective URLs; 4 patients had both cTnI and cTnT above their respective URLs (maximal increase: 4.4-and 3.2-fold over the URL for cTnI and cTnT, respectively); and three samples from 2 patients had cTnI below the URL but cTnT above the URL (1.5-and 1.7-fold increase, respectively). In these two patients creatinine was Ͼ250 mol/L. These results suggested that cTnT might be unexpectedly increased in renal failure. Although obtained with the first-generation troponin T, such a discordance between cTnI and cTnT was reported previously in renal disease [5] . However, a lower URL for cTnI (about 0.6 g/L) would give nearly complete concordance between cTnI and cTnT values. The cTnI URL used in our laboratory corresponds to the value for the diagnosis of acute myocardial infarction, but a cutoff of 0.4 g/L has been used recently to predict the risk of mortality in patients with acute coronary syndrome [6] . The last patient studied in this work had very high cTnI and cTnT values (239 and 17.7 g/L, respectively), associated with a CK 277 times the URL (not shown on the figure) . Thus, our results demonstrated that cTnI and second-generation troponin T showed similar changes in patients with early posttraumatic rhabdomyolysis. In blood, free ("ionized") magnesium (Mg 2ϩ ) is in equilibrium with complexed (protein-bound, and organic or inorganic complexed) species. This equilibrium is influenced by pH and by protein and ligand concentration, both in vivo and in vitro. The phenomenon is well known for calcium; pH influences the serum concentration of free calcium ion (S-cCa 2ϩ ) through the competition between hydrogen ions and calcium ions toward binding sites of protein. Fogh-Andersen [1] proposed the relationship dpcCa 2ϩ /dpH, correcting the measured S-cCa 2ϩ to the standard pH of 7.4, that, although controversial, is widely used in commercial analyzers [2, 3] .
Ionized Magnesium in Serum and
Recently, synthetic neutral carriers for the determination of free magnesium ion concentration (cMg 2ϩ ) have been developed [4 -7] , the selectivity of which toward calcium allows the chemometric correction of the free magnesium measurement in the presence of pathophysiological calcium concentrations [8, 9] . Magnesium bound to protein represents 30 -35% of the total magnesium ion concentration in serum [6 -8, 10] , and, as with calcium, an empirical correction of measured serum free magnesium ion concentration (S-cMg 2ϩ ) to a standard pH can be proposed. The slope of the regression log S-cMg 2ϩ vs pH is ϳϪ0.1 [6, 11] , half that for S-cCa 2ϩ . In the S-cMg 2ϩ range of 0.31-0.76 mmol/L, we found an average value of Ϫ0.117 [8] , which was reproducible during the life-span of the tested electrodes. By contrast, Ising et al. [12] , evaluating the performance of the Kone Microlyte Magnesium assay (magnesium ionophore ETH 5220), found a dependence of the dpcMg 2ϩ /dpH relation on the electrode life-time. According to these authors, the built-in value of Ϫ0.07 was incorrect, and could produce error in the normalized value up to 10%.
We performed the present study on the AVL 988-4 electrolyte analyzer (AVL Medical Instruments) [8] , which uses a highly purified ETH 7025 Mg 2ϩ ionophore, with a typical slope of 13-15 mV/decade in the presence of 1.25 mmol/L calcium background [4] . According to the authors of that report, "with a slope of 15 mV/decade of magnesium in presence of calcium the electrode yielded excellent results on all types of specimen tested" [4] .
We measured both ultrafiltrable (UF) 1 and serum free calcium and magnesium and found that, at a measured ultrafiltrate pH of ϳ8.3, the average ultrafiltrate values were, respectively, 40% and 29% lower than the serum values at actual pH. A difference was expected, and its magnitude prompted us to further investigations.
In the ultrafiltration procedure used, the pH in serum changes, causing a change in S-cCa 2ϩ and S-cMg 2ϩ at the interface serum/ultrafilter membrane. Although AVL states that the formula for the correction of S-cCa 2ϩ is valid only in the pH range of 7.2-7.6, we forced the correction up to pH 8.3. In fact, in several serum samples it was possible to graphically extrapolate the linear trend of the dpcCa 2ϩ /dpH relation up to pH 8.3, with an error not greater than Ϫ10%, as compared with the experimental data. Similarly, for NOVA analyzers, which use the same calcium ionophore as AVL (ETH 1001), the instruction manuals [13] report that, with some limitation, their formulas can be used for pH 6.9 -8.0. Hence, we recalculated in 90 samples, having actual pHs from 7.21 to 7.53, the S-cCa 2ϩ at pH 8. We described elsewhere several other experiments devoted to the explanation of the different behavior of the magnesium ion with respect to the calcium ion [8] . In one of these, based on many reports published previously about the ion binding by bicarbonate [14 -16] , we tested aqueous magnesium chloride solutions with physiological phosphate buffer concentration and ionic strength with increasing bicarbonate concentration: the decrease of magnesium, as measured by the electrode, was Ϫ0.005 mmol/L per 1 mmol/L of added bicarbonate. We worked out an extended correction formula that took into account the effects of both pH and total carbon dioxide concentration (cTCO 2 ):
and used this to recalculate the values of the 68 samples for which cTCO 2 data in ultrafiltrate were available. Although the paired t-test inidicated a significant difference (P Ͻ0.05) between the UF-cMg These last results are in good agreement with those obtained by McGuigan et al. [17] , who used the same ultrafiltration procedure we used but a different mathematical approach. They explained the relevant difference between expected and measured anion-complexed magnesium in ultrafiltrate by a pH-dependent complexing of magnesium to UF anions. They found a linear correlation between UF-cMg 2ϩ and pH, but when the pH of ultrafiltrate was changed with HCl or NaOH, the correlation was not linear. Furthermore, these authors affirmed that by empirically correcting the actual measured values in the ultrafiltrate with this curve, the values came very close to but were not exactly the same as the expected S-cMg2ϩ pH 7.4 . The reason for this small difference (about 0.04 mmol/L) is not clear yet.
Another interesting, and perhaps connected, phenomenon was seen by us [8] and by Altura et al. [18] . We removed carbon dioxide from three pooled sera, which we successively equilibrated back to low pH by tonometry with gaseous CO 2 . An additional loss of CO 2 up to alkaline pH did not change the measured S-cMg 2ϩ [8] . Altura et al. [18] repeatedly froze and thawed serum, measured S-cMg 2ϩ and S-cCa 2ϩ after each cycle on a different instrument (NOVA STAT Profile 8; NOVA Biomedical), and found no change of S-cMg 2ϩ as pH was increasing from 7.45 to 7.80. Nonetheless, in both experiments the change of S-cCa 2ϩ with pH was as expected, with a slope equal to Ϫ0.23 in our experiments and a S-cCa 2ϩ decrease of Ϫ0.04 mmol/L per 0.1 pH unit in the Altura experiment.
Taking into account the TCO 2 concentration, we were able to correct the apparent higher degree of binding of magnesium ion than of calcium ion, but we probably overcorrected. As the medium becomes more and more alkaline, the magnesium ion may be sequestered in a chemical species (not necessarily magnesium bicarbonate) and not detected by the electrode in the same way as the free magnesium ion. Acidification of the medium with gaseous CO 2 cannot free the sequestered magnesium ion. The easiest explanation is that at high pH or low temperature, an aliquot of magnesium ion is definitively sequestered in the form of magnesium hydroxide, and hence is not sensed by the ionophore.
However, according to Czaban et al. [16] , because of the change of ion environment, the change of activity coefficient and liquid junction potential error could modify the ion data as NaHCO 3 is substituted for NaCl. This phenomenon, described for sodium, could be also extended to magnesium.
Despite the extensive mathematical processing by both the AVL analyzer and us, the reported data demonstrate, at least with this kind of ionophore, that magnesium ion solutions do not exhibit the same behavior as calcium ion solutions, as far as pH changes in the medium are concerned. For other reasons, the data by Ising et al. [12] confirm these findings.
We are grateful to Angelo Manzoni (Instrumentation Laboratory) for careful review of the manuscript and helpful discussions. Standardization of immunoassays for estradiol-17␤ (E2) for accuracy was considered in the "Estradiol International Workshops" [1] . There, industry asked our laboratory to provide them with a means to evaluate the accuracy/specificity of their E2 test systems. In answer to this demand, we developed and made commercially available an accuracy-based panel of patient specimens. The results of the method comparisons subsequently performed by industry are presented below. Perspectives to use this exercise as a basis for further international standardization efforts are given.
The reference panel (tradename: SysRef E2) was prepared through a joint venture between our university laboratory and Scantibodies Laboratory, Inc. (SLI, Santee, CA). To allow a realistic evaluation of routine test systems, the panel consisted of sera from single donations and had E2 concentrations and matrices of clinical relevance: 5 sera were from men and 12 from women. The latter were either in the fertile stage of life, some of them at a defined stage of the menstrual cycle, or postmenopausal. For another five female sera, we deviated from the "single donation" approach by supplementing them with serum from a pregnant woman. This compromise was made because it was considered desirable to include sera with concentrations typical for ovulation-induction therapy, for which it was, unfortunately, not possible to obtain a sufficient volume of blood from such women. The study showed, however, that the samples did behave in the method comparison in an identical manner as the single-donation sera. All blood donations were allowed to clot for 1 h at room temperature and were separated by centrifugation. No preservatives were added. The resulting fresh sera (ϳ200 mL) were stored for 3 days at 4°C, then sterile-filtered, placed in 1-mL aliquots in screwcapped Eppendorf R cups, frozen, and stored at SLI at Ϫ70°C. All donations were tested for infectious diseases and were found negative for HIV-1/2 antibody, hepatitis C virus antibody, syphilis, and hepatitis B surface antigen. The reference panel was delivered in sets of three 1-mL aliquots per serum. Shipment to the customers was done on solid CO 2 . At the customer's laboratory, the sera were to be stored at Ϫ20°C, under which conditions they should be stable for 12 months. We recommended that after thawing at room temperature, the samples should be used within a time period of 8 h and never thawed and frozen several times.
The target values were determined at the University of Gent by use of a reference method based on isotope dilution-gas chromatography/mass spectrometry (ID-GC/MS) [2] . The measurement protocol consisted of duplicate analyses of each sample on two different occasions. Consistency of measurements was verified by internal accuracy assessment, for which purpose the Certified Reference Materials (CRMs) 577 and 578 from the Community Bureau of Reference (BCR, Brussels, Belgium) were used [3] . The mean deviations from the CRM targets were Ϫ0.5% (CRM 577; certified concentration, 689 Ϯ 32 pmol/L) and Ϫ1.2% (CRM 578; 1340 Ϯ 70 pmol/L). The concentrations of E2 in the 22 sera ranged from 14.67 to 3329 pmol/L. The CVs, based on four measurements, ranged from 0.31% to 2.2%.
The E2 routine test systems evaluated in the study (16 in total from 11 manufacturers, see Acknowledgments) comprised manually performed single-analyte immunoassays and automated multi-analyte systems, all direct methods making use of radioactive and nonradioactive labels. The study was conducted on a strictly confidential basis, which means that the identity of the tested immunoassay systems was disclosed only to the scientific organizer of the study. All measurements with the routine test systems were performed in the application laboratory of the participating companies. In most of the cases, the samples were analyzed in replicate (although not always explicitly mentioned), sometimes even with different reagent batches and on different instruments. The mean values were always considered for the comparison.
The results obtained were investigated by linear least 
